EuroEyes Announces Availability of 2026 Interim Report and Outlines Shareholder Communication Options

Bulletin Express
Yesterday

EuroEyes International Eye Clinic Limited released a shareholder notification dated 22 September 2026 confirming that its 2026 Interim Report is now accessible in both English and Chinese on the company’s website (ir.euroeyes.hk) and on the Hong Kong Stock Exchange’s HKEXnews platform (www.hkexnews.hk).

The board recommends stakeholders use the online version for immediate access. Non-registered shareholders who are unable to view or receive the electronic document may request a hard copy—free of charge—by completing and returning the enclosed request form to the Hong Kong branch share registrar, Tricor Investor Services Limited, via post (pre-paid label provided) or email (1846-ecom@vistra.com).

Investors holding shares through intermediaries (banks, brokers, custodians, nominees or HKSCC Nominees Limited) can opt to receive future corporate communications electronically by supplying their functional email address to those intermediaries. Until a valid email is on record, such investors will continue to receive printed notices of publication by post.

Queries can be directed to Tricor Investor Services Limited’s hotline on +852 2980 1333 during business hours (9:00 a.m.–6:00 p.m., Monday to Friday, excluding public holidays).

The notification was issued by Dr. Jørn Slot Jørgensen, Chairman and Executive Director of EuroEyes International Eye Clinic Limited, on behalf of the board.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10